In accordance with these findings, treatment with the HSF1 inhibitor KRIBB11 triggered a pronounced, highly significant, decline in proliferation and increase of apoptotic cell death in HCC3-4 and HCC4-4 cells ( Supplementary Figure 6 ).
← all excerpts
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis.
1
—
—